Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06696755

1 development in the corpus

NCT06696755

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · PHASE 2 TRIAL

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

ClinicalTrials.gov

Phase 2 trial of an investigational agent for bipolar depression with surrogate mood and safety endpoints; study is actively recruiting with no results posted.

PreliminaryNCT06696755 Icalcaprant Placebo for Icalcaprant

Reported

Planned enrollment195

Phase2

Number of treatment arms3

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support